A rating of 58 puts Canopy Growth Corp (CGC) near the middle of the Drug Manufacturers - Specialty & Generic industry according to InvestorsObserver. Canopy Growth Corp's score of 58 means it scores higher than 58% of stocks in the industry. Canopy Growth Corp also received an overall rating of 34, putting it above 34% of all stocks. Drug Manufacturers - Specialty & Generic is ranked 122 out of the 148 industries.
What do These Ratings Mean?
Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. Investors Observer allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 34 would rank higher than 34 percent of all stocks.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.
What's Happening With Canopy Growth Corp Stock Today?
Canopy Growth Corp (CGC) stock is trading at $15.52 as of 12:32 PM on Friday, May 8, a gain of $0.08, or 0.52% from the previous closing price of $15.44. The stock has traded between $15.15 and $15.60 so far today. Volume today is less active than usual. So far 2,208,784 shares have traded compared to average volume of 5,266,917 shares.
To see InvestorsObserver's Sentiment Score for Canopy Growth Corp click here.
